EUVIMEDEUVIMED entdecken
Crossref

Clinical trials in complementary and alternative medicine – the myth of limitations

Tomasz Rzepiński, Piotr Tabaczewski

Journal of Medical Science · 2016

DOI: 10.20883/161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Science, 2016. Verfasst von Tomasz Rzepiński und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The paper aims to dispute common arguments put forward by practitioners of complementary and alternative medicine (CAM) in discussions against conducting clinical trials in CAM treatment protocols. It is argued that CAM therapies cannot be evaluated by the same criteria as those applied in conventional medicine due to specificity of CAM. This paper suggests that this line of thought undermines not only the validity of CAM therapies, but, importantly, is delaying understanding their therapeutical value. We also argue that despite apparent differences in approach both conventional medicine and CAM aim to improve human well being therefore CAM should be validated with well established and widely accepted process of balancing of risks and benefits of individual therapies as in conventional medicine clinical trials.

Zitieren

APA

Rzepiński, T., & Tabaczewski, P. (2016). Clinical trials in complementary and alternative medicine – the myth of limitations. Journal of Medical Science. https://doi.org/10.20883/161

Vancouver

Rzepiński T, Tabaczewski P. Clinical trials in complementary and alternative medicine – the myth of limitations. Journal of Medical Science. 2016. doi:10.20883/161

BibTeX
@article{Rzepiski2016,
  author = {Rzepiński, Tomasz and Tabaczewski, Piotr},
  title = {Clinical trials in complementary and alternative medicine – the myth of limitations},
  journal = {Journal of Medical Science},
  year = {2016},
  doi = {10.20883/161}
}
Kostenlos starten →